Tuesday, February 17, 2015

Eliglustat Shows Promising Results in Gaucher Disease Type 1

Treatment with the drug eliglustat in untreated adults with Gaucher disease type 1 showed significant improvements in liver and spleen size, hemoglobin level, and platelet count. Gaucher disease type 1 is a genetic disease in which there is improper metabolism due to a defect in an enzyme. It is characterized by enlargement of the spleen and liver, anemia, low blood platelets, chronic bone pain, and the failure to grow properly. The disease is a chronic and progressive ...

Read More

No comments:

Post a Comment